Literature DB >> 8268143

Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis.

C W Choi1, D R Cha, Y J Kwon, W Y Cho, H J Pyo, H K Kim.   

Abstract

Runyon group IV atypical mycobacteria, Mycobacterium fortuitum, is an environmental organism and is capable of producing a variety of clinical infections such as cutaneous infection, abscess and pulmonary and ocular infection. Rarely, it has been a documented cause of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD). We report a case of M. fortuitum peritonitis in a patient undergoing CAPD and emphasize the importance of mycobacterial cultures in patients with CAPD-associated peritonitis whose routine culturing yields no organisms repeatedly.

Entities:  

Mesh:

Year:  1993        PMID: 8268143      PMCID: PMC4532079          DOI: 10.3904/kjim.1993.8.1.25

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  16 in total

1.  Problems in diagnosis and therapy of Mycobacterium fortuitum infections.

Authors:  J R Dalovisio; G A Pankey
Journal:  Am Rev Respir Dis       Date:  1978-04

2.  Mycobacteriosis in patients with chronic renal failure.

Authors:  E A Rutsky; S G Rostand
Journal:  Arch Intern Med       Date:  1980-01

Review 3.  Nontuberculous mycobacterial peritonitis during continuous ambulatory peritoneal dialysis: case report and review of diagnostic and therapeutic strategies.

Authors:  R B Dunmire; J A Breyer
Journal:  Am J Kidney Dis       Date:  1991-07       Impact factor: 8.860

4.  Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex.

Authors:  P C Hoffman; D W Fraser; F Robicsek; P R O'Bar; C U Mauney
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

5.  Mycobacterium chelonae peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  T L Merlin; A H Tzamaloukas
Journal:  Am J Clin Pathol       Date:  1989-06       Impact factor: 2.493

6.  Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.

Authors:  J R Dalovisio; G A Pankey; R J Wallace; D B Jones
Journal:  Rev Infect Dis       Date:  1981 Sep-Oct

Review 7.  Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review.

Authors:  I I Raad; S Vartivarian; A Khan; G P Bodey
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

8.  Nontuberculous mycobacterial peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  J P Pulliam; D D Vernon; S R Alexander; A I Hartstein; T A Golper
Journal:  Am J Kidney Dis       Date:  1983-05       Impact factor: 8.860

9.  Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.

Authors:  R J Wallace; J M Swenson; V A Silcox; M G Bullen
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

10.  Mycobacterium fortuitum peritonitis associated with continuous ambulatory peritoneal dialysis.

Authors:  G L Woods; G S Hall; M J Schreiber
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

View more
  2 in total

1.  Peritonitis from Mycobacterium wolinskyi in a chronic peritoneal dialysis patient.

Authors:  Nithin Karakala; Lisa L Steed; Michael E Ullian
Journal:  Int Urol Nephrol       Date:  2011-11-30       Impact factor: 2.370

Review 2.  Mycobacterium fortuitum as a cause of peritoneal dialysis-associated peritonitis: case report and review of the literature.

Authors:  Simon H Jiang; Darren M Roberts; Andrew H Dawson; Meg Jardine
Journal:  BMC Nephrol       Date:  2012-06-08       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.